Bacillus Calmette-Guérin
No
Yes
Cancer Drug and Clinical Indication listed in the MediShield Life Outpatient Cancer Drug List
Standard Drug List
Active ingredient: Bacillus Calmette-Guérin
General information
Subsidy Information and Financing Scheme
[SDL] Bacillus Calmette-Guerin Solution For Intravesical Use 12.5 mg, 40 mg, 80 mg
[MSHL] Bacillus Calmette-Guerin (BCG) Solution For Intravesical Use 12.5 mg, 40 mg, 80 mg
For cancer treatment.
Drug Guidance for Subsidy
Not Applicable
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Availability information
Formulation | Public Healthcare Institution |
|---|---|
Onco-BCG Solution For Intravesical Use 40 mg |
|
OncoTICE Solution For Intravesical Use 12.5 mg |
|
Immunobladder Solution For Intravesical Use 80 mg |
|
List of monographs containing this active ingredient
Bacillus Calmette-Guérin [ONCO-BCG]
